Institutional investors hold a majority ownership of ZTS through the 95.84% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended September 2017, these large investors purchased a net $1.5 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ALLIANCEBERNSTEIN LP Bought 4.4 Million shares of Zoetis Inc
CAPITAL RESEARCH & MANAGEMENT CO... Bought 4.0 Million shares of Zoetis Inc
MANAGED ACCOUNT ADVISORS LLC Bought 2.0 Million shares of Zoetis Inc